DOI:
10.1055/s-00035024
Thrombosis and Haemostasis
LinksClose Window
References
Massicotte P, Julian JA, Gent M. , et al; PROTEKT Study Group.
An open-label randomized controlled trial of low molecular weight heparin for the prevention of central venous line-related thrombotic complications in children: the PROTEKT trial.
Thromb Res 2003;
109 (2-3): 101-108
Access:
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.